JANUMET is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Merck Sharp & Dohme Corp.. The primary component is Sitagliptin Phosphate; Metformin Hydrochloride.
| Product ID | 0006-0577_51b7ac5d-0947-4d97-bd06-a56cb262145c |
| NDC | 0006-0577 |
| Product Type | Human Prescription Drug |
| Proprietary Name | JANUMET |
| Generic Name | Sitagliptin And Metformin Hydrochloride |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2007-03-30 |
| Marketing Category | NDA / NDA |
| Application Number | NDA022044 |
| Labeler Name | Merck Sharp & Dohme Corp. |
| Substance Name | SITAGLIPTIN PHOSPHATE; METFORMIN HYDROCHLORIDE |
| Active Ingredient Strength | 50 mg/1; mg/1 |
| Pharm Classes | Dipeptidyl Peptidase 4 Inhibitor [EPC],Dipeptidyl Peptidase 4 Inhibitors [MoA],Biguanide [EPC],Biguanides [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 2007-03-30 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA022044 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2015-09-09 |
| Marketing Category | NDA |
| Application Number | NDA022044 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2007-03-30 |
| Marketing Category | NDA |
| Application Number | NDA022044 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2007-03-30 |
| Marketing Category | NDA |
| Application Number | NDA022044 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2010-05-31 |
| Marketing End Date | 2015-09-09 |
| Marketing Category | NDA |
| Application Number | NDA022044 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2007-03-30 |
| Marketing Category | NDA |
| Application Number | NDA022044 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2007-03-30 |
| Marketing Category | NDA |
| Application Number | NDA022044 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2007-03-30 |
| Marketing Category | NDA |
| Application Number | NDA022044 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2007-03-30 |
| Marketing End Date | 2011-10-05 |
| Marketing Category | NDA |
| Application Number | NDA022044 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2007-03-30 |
| Ingredient | Strength |
|---|---|
| SITAGLIPTIN PHOSPHATE | 50 mg/1 |
| SPL SET ID: | d19c7ed0-ad5c-426e-b2df-722508f97d67 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0006-0078 | JANUMET | sitagliptin and metformin hydrochloride |
| 0006-0080 | JANUMET | sitagliptin and metformin hydrochloride |
| 0006-0081 | JANUMET | sitagliptin and metformin hydrochloride |
| 0006-0575 | JANUMET | SITAGLIPTIN and METFORMIN HYDROCHLORIDE |
| 0006-0577 | JANUMET | SITAGLIPTIN and METFORMIN HYDROCHLORIDE |
| 50090-4411 | JANUMET | sitagliptin and metformin hydrochloride |
| 50090-5618 | JANUMET | SITAGLIPTIN and METFORMIN HYDROCHLORIDE |
| 70518-2548 | JANUMET | SITAGLIPTIN and METFORMIN HYDROCHLORIDE |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() JANUMET 78934999 3363805 Live/Registered |
MERCK SHARP & DOHME CORP. 2006-07-21 |
![]() JANUMET 78773912 3374065 Live/Registered |
MERCK SHARP & DOHME CORP. 2005-12-15 |